N/A N=78 Randomized Treatment

Randomized Control Trial of Second Stage of Labor

Labor Complications

Bottom Line

View on ClinicalTrials.gov: NCT02101515 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2018

Primary outcome: Primary: Number of Patients Delivered by Cesarean — 16; 8 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Length of Second Stage (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: Female
Sponsor: Thomas Jefferson University
Primary completion: Jul 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Patients Delivered by Cesarean	16; 8	—
SECONDARY Number of Newborns With Umbilical Artery pH < 7.10	0; 0	—
SECONDARY Postpartum Hemorrhage	3; 8	—

Summary

The hypothesis of this study is that extending the second stage of labor beyond current American College of Obstetricians and Gynecologists suggestions can reduce the cesarean delivery rate. The cesarean delivery rate in the United States is around 30 percent. This is a number that continues to be increasing over the last few decades and will continue to climb. Each subsequent cesarean section puts the mother and baby at increased risk for postpartum hemorrhage, bowel and bladder injury, abnormal placentation, febrile morbidity and death. The most common reason for a cesarean delivery is a repeat cesarean delivery. One way to reduce this number is to prevent the first cesarean delivery. The aim of this study is evaluate if extending the second stage of labor affects the cesarean delivery rate and subsequent perinatal morbidity.

Eligibility Criteria

Inclusion Criteria

Nulliparous women
singleton pregnancies
cephalic presentation
36.0-41.6 weeks
age 18 and older

Exclusion Criteria

Category 3 fetal heart tracing
major congenital anomalies
multiples
planned cesarean delivery
intrauterine fetal demise
Trial of labor after cesarean

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02101515). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.